Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2110 | 115 | 0.4012 | 0.3143 | 0.0545 | 0.0600 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1897 | 677 | 0.3045 | 0.2911 | 0.3569 | 0.3460 |
MZ7-mel | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1692 | 86 | 0.3230 | 0.2758 | 0.0508 | 0.0483 |
A-375 | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 1 | 2803 | 103 | 0.1469 | 0.1343 | 0.0367 | 0.0352 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1897 | 707 | 0.2971 | 0.2711 | 0.3727 | 0.3806 |
MZ7-mel | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1700 | 292 | 0.2831 | 0.3589 | 0.1718 | 0.1593 |
COLO 858 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 1 | 952 | 361 | 0.1356 | 0.1295 | 0.3792 | 0.3690 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 3002 | 210 | 0.6970 | 0.7092 | 0.0700 | 0.0818 |
MZ7-mel | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 1165 | 126 | 0.2089 | 0.2583 | 0.1082 | 0.1001 |